A Phase I Study of Fenretinide (NSC #374551) in Children With High Risk Solid Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fenretinide (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 07 Feb 2013 Biomarkers information updated
- 25 Sep 2005 New trial record.